Sign inGet started

MOTT DAVID M

Insider CIK 1219871 · NVAX Director · ILIU 10% owner · CVT 10% owner · PHAS 10% owner · GLYC 10% owner · AKAO 10% owner · AVEO 10% owner · WDAY 10% owner · MM 10% owner · HIVE 10% owner · BOX 10% owner · MULE 10% owner · TCON 10% owner · CASC 10% owner · CRCM 10% owner · ARDX Director, 10% owner · APPN 10% owner · MRSN Director, 10% owner · GNCA 10% owner · CLVS 10% owner · ROKA 10% owner · NET 10% owner · OMTH Director, 10% owner · RARX 10% owner · TSRO Director, 10% owner · RGLS 10% owner · SPT 10% owner · MIRN 10% owner · CERC 10% owner · DERM 10% owner · GRTX 10% owner · TRVI 10% owner · EPZM Director, 10% owner · LOXO 10% owner · ADAP Director, 10% owner · RYTM 10% owner · IMRA Director · ESTC 10% owner · NITE Director, 10% owner · SURF 10% owner · OYST 10% owner · MIRM 10% owner · ABIO 10% owner

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NVAX NOVAVAX INC M Exercise deriv2026-06-202026-06-2318,880— $00SEC↗
NVAX NOVAVAX INC M Exercise2026-06-202026-06-2318,880— $079,770SEC↗
NVAX NOVAVAX INC A Award deriv2026-06-182026-06-2314,180— $014,180SEC↗
NVAX NOVAVAX INC A Award deriv2026-06-182026-06-2321,270— $021,270SEC↗
ARDX ARDELYX, INC. A Award deriv2026-06-162026-06-1839,715— $039,715SEC↗
ARDX ARDELYX, INC. A Award2026-06-162026-06-1820,282— $03,323,200SEC↗
ARDX ARDELYX, INC. A Award2026-06-162026-06-1826,455— $03,349,655SEC↗
ARDX ARDELYX, INC. P Buy2026-02-202026-02-23333,333$5.84 $1.95M3,302,918SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06264— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-062,460— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06400— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-061,011— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-061,000— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06788— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06368— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-062,200— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06734— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-061,800— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06740— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-061,002— $00SEC↗
MRSN Mersana Therapeutics, Inc. D To issuer deriv2026-01-062026-01-06181— $00SEC↗
MRSN Mersana Therapeutics, Inc. U Tender2026-01-062026-01-0623,546— $00SEC↗
MRSN Mersana Therapeutics, Inc. U Tender2026-01-062026-01-06383— $00SEC↗
NVAX NOVAVAX INC A Award deriv2025-06-202025-06-2428,326$6.42 $181.9K28,326SEC↗
NVAX NOVAVAX INC A Award deriv2025-06-202025-06-2418,884— $018,884SEC↗
ARDX ARDELYX, INC. A Award deriv2025-06-182025-06-2354,059— $054,059SEC↗
ARDX ARDELYX, INC. A Award2025-06-182025-06-2341,551— $02,969,585SEC↗
ARDX ARDELYX, INC. A Award2025-06-182025-06-2331,163— $02,928,034SEC↗
ARDX ARDELYX, INC. P Buy2025-06-162025-06-18200,000$3.63 $726.0K2,896,871SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2025-06-122025-06-1361,500— $061,500SEC↗
NVAX NOVAVAX INC M Exercise deriv2025-06-122025-06-1310,420— $00SEC↗
NVAX NOVAVAX INC M Exercise2025-06-122025-06-1310,420— $060,890SEC↗
ARDX ARDELYX, INC. P Buy2025-06-092025-06-11200,000$3.69 $738.0K2,696,871SEC↗
ARDX ARDELYX, INC. P Buy2025-05-152025-05-19100,000$3.29 $329.0K2,496,871SEC↗
ARDX ARDELYX, INC. P Buy2025-05-022025-05-05381,377$4.22 $1.61M2,396,871SEC↗
ARDX ARDELYX, INC. P Buy2025-02-242025-02-2677,729$5.00 $388.6K2,015,494SEC↗
ARDX ARDELYX, INC. P Buy2025-01-212025-01-22199,000$4.99 $993.0K1,937,765SEC↗
ARDX ARDELYX, INC. M Exercise deriv2024-12-262024-12-27100,000— $00SEC↗
ARDX ARDELYX, INC. M Exercise2024-12-262024-12-27100,000$0.55 $55.0K1,738,765SEC↗
ARDX ARDELYX, INC. P Buy2024-12-192024-12-23213,300$4.67 $996.1K1,638,765SEC↗
ARDX ARDELYX, INC. P Buy2024-11-132024-11-14215,868$4.62 $997.3K1,425,465SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2024-07-012024-07-011,583,214— $01,583,214SEC↗
ARDX ARDELYX, INC. A Award deriv2024-06-142024-06-1740,243— $040,243SEC↗
ARDX ARDELYX, INC. A Award2024-06-142024-06-1717,322— $01,209,597SEC↗
NVAX NOVAVAX INC A Award deriv2024-06-122024-06-1410,420— $010,420SEC↗
NVAX NOVAVAX INC M Exercise deriv2024-06-122024-06-146,670— $00SEC↗
NVAX NOVAVAX INC A Award deriv2024-06-122024-06-1415,630$15.86 $247.9K15,630SEC↗
NVAX NOVAVAX INC M Exercise2024-06-122024-06-146,670— $050,470SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2024-06-112024-06-1255,000— $055,000SEC↗
MRSN Mersana Therapeutics, Inc. A Award2024-01-022024-01-048,810— $0588,694SEC↗
MRSN Mersana Therapeutics, Inc. A Award2023-10-022023-10-0415,873— $0579,884SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2023-07-032023-07-031,462,927— $01,462,927SEC↗
MRSN Mersana Therapeutics, Inc. A Award2023-07-032023-07-066,079— $0564,011SEC↗
ARDX ARDELYX, INC. A Award deriv2023-06-152023-06-1649,237— $049,237SEC↗
ARDX ARDELYX, INC. A Award2023-06-152023-06-1625,510— $01,192,275SEC↗
NVAX NOVAVAX INC A Award deriv2023-06-122023-06-136,670— $06,670SEC↗
NVAX NOVAVAX INC A Award deriv2023-06-122023-06-137,710— $07,710SEC↗
NVAX NOVAVAX INC M Exercise deriv2023-06-102023-06-133,100— $00SEC↗
NVAX NOVAVAX INC M Exercise2023-06-102023-06-133,100— $043,800SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2023-06-082023-06-1218,355— $018,355SEC↗
MRSN Mersana Therapeutics, Inc. A Award2023-06-082023-06-1214,467— $0557,932SEC↗
MRSN Mersana Therapeutics, Inc. A Award2023-04-032023-04-054,866— $0543,465SEC↗
ARDX ARDELYX, INC. P Buy2022-11-172022-11-17567,000$1.76 $997.9K1,166,765SEC↗
EPZM Epizyme, Inc. U Tender2022-08-122022-08-16106,959— $00SEC↗
EPZM Epizyme, Inc. U Tender2022-08-122022-08-16215,494— $08,994SEC↗
EPZM Epizyme, Inc. D To issuer2022-08-122022-08-168,994— $00SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2022-07-012022-07-011,000,439— $01,000,439SEC↗
EPZM Epizyme, Inc. A Award2022-06-302022-07-0516,156$1.47 $23.7K224,488SEC↗
NVAX NOVAVAX INC M Exercise deriv2022-06-172022-06-21700— $00SEC↗
NVAX NOVAVAX INC M Exercise2022-06-172022-06-21700— $040,700SEC↗
ARDX ARDELYX, INC. A Award deriv2022-06-152022-06-21100,000— $0100,000SEC↗
ARDX ARDELYX, INC. A Award2022-06-152022-06-21182,481— $0599,765SEC↗
NVAX NOVAVAX INC A Award deriv2022-06-102022-06-144,600— $04,600SEC↗
NVAX NOVAVAX INC A Award deriv2022-06-102022-06-143,100— $03,100SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2022-06-092022-06-1045,000— $045,000SEC↗
IMRA IMARA Inc. A Award deriv2022-06-022022-06-038,500— $08,500SEC↗
EPZM Epizyme, Inc. A Award deriv2022-05-172022-05-1941,006— $041,006SEC↗
EPZM Epizyme, Inc. A Award2022-05-172022-05-198,994— $0208,332SEC↗
EPZM Epizyme, Inc. A Award2022-03-312022-04-0120,653$1.15 $23.8K199,338SEC↗
IMRA IMARA Inc. P Buy2022-02-232022-02-2335,257$1.46 $51.5K229,224SEC↗
IMRA IMARA Inc. P Buy2022-02-222022-02-2365,817$1.56 $102.7K193,967SEC↗
IMRA IMARA Inc. P Buy2022-02-182022-02-2350,398$1.30 $65.5K128,150SEC↗
IMRA IMARA Inc. P Buy2022-02-172022-02-1714,595$1.17 $17.1K77,752SEC↗
IMRA IMARA Inc. P Buy2022-02-162022-02-1711,779$1.20 $14.1K63,157SEC↗
IMRA IMARA Inc. P Buy2022-02-152022-02-1719,552$1.20 $23.5K51,378SEC↗
IMRA IMARA Inc. P Buy2022-02-142022-02-148,500$1.18 $10.0K31,826SEC↗
IMRA IMARA Inc. P Buy2022-02-112022-02-1414,573$1.23 $17.9K23,326SEC↗
IMRA IMARA Inc. P Buy2022-02-102022-02-148,753$1.29 $11.3K8,753SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2022-01-032022-01-0518,518— $018,518SEC↗
EPZM Epizyme, Inc. A Award2021-12-312022-01-049,500$2.50 $23.8K178,685SEC↗
EPZM Epizyme, Inc. A Award2021-09-302021-10-014,640$5.12 $23.8K169,185SEC↗
NVAX NOVAVAX INC S Sale2021-09-232021-09-245,728$251.32 $1.44M59,233SEC↗
NVAX NOVAVAX INC S Sale2021-09-232021-09-247,557$252.56 $1.91M51,676SEC↗
NVAX NOVAVAX INC S Sale2021-09-232021-09-241,200$255.38 $306.5K40,000SEC↗
NVAX NOVAVAX INC S Sale2021-09-232021-09-247,744$253.46 $1.96M43,932SEC↗
NVAX NOVAVAX INC S Sale2021-09-232021-09-242,732$254.46 $695.2K41,200SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2021-07-012021-07-02579,494— $0579,494SEC↗
EPZM Epizyme, Inc. A Award2021-06-302021-07-012,858$8.31 $23.7K164,545SEC↗
IMRA IMARA Inc. A Award deriv2021-06-292021-06-307,728— $07,728SEC↗
NVAX NOVAVAX INC A Award deriv2021-06-172021-06-221,300— $01,300SEC↗
NVAX NOVAVAX INC A Award deriv2021-06-172021-06-22700— $0700SEC↗
ARDX ARDELYX, INC. A Award deriv2021-06-162021-06-2132,765— $032,765SEC↗
EPZM Epizyme, Inc. A Award deriv2021-06-112021-06-1540,559— $040,559SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2021-06-112021-06-1525,050— $025,050SEC↗
EPZM Epizyme, Inc. A Award2021-06-112021-06-158,060— $0161,687SEC↗
EPZM Epizyme, Inc. A Award2021-03-312021-04-012,727$8.71 $23.8K153,627SEC↗
EPZM Epizyme, Inc. P Buy2021-03-262021-03-29217$7.80 $1.7K150,900SEC↗
EPZM Epizyme, Inc. P Buy2021-03-262021-03-2934,269$7.97 $273.1K150,683SEC↗
EPZM Epizyme, Inc. P Buy2021-03-252021-03-2928,231$7.98 $225.3K116,414SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2021-01-152021-01-204,528— $04,528SEC↗
EPZM Epizyme, Inc. A Award2020-12-312021-01-052,158$10.86 $23.4K88,183SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-12-142020-12-15486— $09,595SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-12-142020-12-151,096— $09,109SEC↗
ARDX ARDELYX, INC. P Buy2020-12-102020-12-10170,000$5.89 $1.00M417,284SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-12-012020-12-031,117— $07,517SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-12-012020-12-03496— $08,013SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-11-092020-11-121,112— $06,400SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-11-092020-11-12496— $05,288SEC↗
EPZM Epizyme, Inc. A Award2020-09-302020-10-011,965$11.93 $23.4K86,025SEC↗
EPZM Epizyme, Inc. A Award deriv2020-09-222020-09-2850,000— $050,000SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-09-142020-11-12496— $04,792SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-09-142020-11-121,106— $04,296SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2020-07-012020-07-01226,753— $0226,753SEC↗
EPZM Epizyme, Inc. A Award2020-06-302020-07-011,459$16.06 $23.4K84,060SEC↗
EPZM Epizyme, Inc. P Buy2020-06-262020-06-2662,019$16.03 $994.2K82,601SEC↗
NVAX NOVAVAX INC A Award deriv2020-06-252020-06-264,400— $04,400SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2020-06-252020-06-299,200— $09,200SEC↗
ARDX ARDELYX, INC. P Buy2020-06-252020-06-2668,373$6.96 $475.9K247,284SEC↗
ARDX ARDELYX, INC. P Buy2020-06-242020-06-2672,598$6.75 $490.0K178,911SEC↗
ARDX ARDELYX, INC. P Buy2020-06-222020-06-244,673$6.75 $31.5K106,313SEC↗
EPZM Epizyme, Inc. J Other2020-06-182020-06-2267,662— $0106,959SEC↗
NVAX NOVAVAX INC A Award deriv2020-06-162020-06-188,000— $08,000SEC↗
ARDX ARDELYX, INC. J Other2020-06-102020-06-111,079— $0101,640SEC↗
ARDX ARDELYX, INC. A Award deriv2020-06-092020-06-1175,000— $075,000SEC↗
ARDX ARDELYX, INC. A Award deriv2020-06-092020-06-1123,500— $023,500SEC↗
ARDX ARDELYX, INC. A Award2020-06-092020-06-1112,995— $0100,561SEC↗
EPZM Epizyme, Inc. A Award deriv2020-05-292020-06-0214,013— $014,013SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-04-092020-04-132,197— $02,197SEC↗
MRSN Mersana Therapeutics, Inc. J Other2020-04-092020-04-13993— $03,190SEC↗
MRSN Mersana Therapeutics, Inc. P Buy2020-04-072020-04-09538,599$5.59 $3.01M538,599SEC↗
EPZM Epizyme, Inc. A Award2020-03-312020-04-021,512$15.51 $23.5K20,582SEC↗
IMRA IMARA Inc. A Award deriv2020-03-162020-03-1615,457— $015,457SEC↗
ADAP Adaptimmune Therapeutics P P Buy2020-01-242020-01-287,500,000$0.67 $5.03M19,500,000SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2020-01-022020-01-0319,713— $019,713SEC↗
EPZM Epizyme, Inc. A Award2019-12-312020-01-03952$24.60 $23.4K19,070SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242019-12-26900,900$6.66 $6.00M900,900SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-12-242019-12-269,009,000$0.13 $1.17M9,009,000SEC↗
SPT Sprout Social, Inc. C Conversion deriv2019-12-172019-12-186,086,620— $00SEC↗
SPT Sprout Social, Inc. C Conversion deriv2019-12-172019-12-181,837,275— $00SEC↗
SPT Sprout Social, Inc. C Conversion deriv2019-12-172019-12-18832,126— $00SEC↗
SPT Sprout Social, Inc. C Conversion deriv2019-12-172019-12-18268,679— $00SEC↗
SPT Sprout Social, Inc. C Conversion2019-12-172019-12-181,837,275— $07,923,895SEC↗
SPT Sprout Social, Inc. C Conversion2019-12-172019-12-18268,679— $09,024,700SEC↗
SPT Sprout Social, Inc. C Conversion2019-12-172019-12-18832,126— $08,756,021SEC↗
SPT Sprout Social, Inc. C Conversion2019-12-172019-12-186,086,620— $06,086,620SEC↗
ARDX ARDELYX, INC. A Award2019-12-092019-12-09400,000$6.25 $2.50M3,482,186SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2019-11-122019-11-129,600,000— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2019-11-122019-11-121,354,829— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion deriv2019-11-122019-11-128,975,000— $00SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2019-11-122019-11-12267,935— $03,941,381SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2019-11-122019-11-121,774,922— $01,774,922SEC↗
GRTX Galera Therapeutics, Inc. C Conversion2019-11-122019-11-121,898,524— $03,673,446SEC↗
GRTX Galera Therapeutics, Inc. P Buy2019-11-122019-11-12416,666$12.00 $5.00M4,358,047SEC↗
OYST Oyster Point Pharma, Inc. C Conversion deriv2019-11-042019-11-043,606,282— $00SEC↗
OYST Oyster Point Pharma, Inc. C Conversion deriv2019-11-042019-11-041,061,547— $00SEC↗
OYST Oyster Point Pharma, Inc. C Conversion2019-11-042019-11-041,061,547— $04,990,287SEC↗
OYST Oyster Point Pharma, Inc. P Buy2019-11-042019-11-04935,000$16.00 $14.96M5,925,287SEC↗
OYST Oyster Point Pharma, Inc. C Conversion2019-11-042019-11-043,606,282— $03,928,740SEC↗
EPZM Epizyme, Inc. A Award2019-09-302019-10-022,271$10.32 $23.4K18,118SEC↗
NET Cloudflare, Inc. C Conversion deriv2019-09-172019-09-1842,463,920— $048,588,474SEC↗
NET Cloudflare, Inc. C Conversion deriv2019-09-172019-09-184,059,376— $00SEC↗
NET Cloudflare, Inc. C Conversion deriv2019-09-172019-09-187,183,310— $00SEC↗
NET Cloudflare, Inc. C Conversion deriv2019-09-172019-09-1835,280,610— $00SEC↗
NET Cloudflare, Inc. C Conversion2019-09-172019-09-184,059,376— $04,059,376SEC↗
MIRM Mirum Pharmaceuticals, Inc C Conversion deriv2019-07-222019-07-2429,889,945— $00SEC↗
MIRM Mirum Pharmaceuticals, Inc P Buy2019-07-222019-07-24450,000$15.00 $6.75M4,186,243SEC↗
MIRM Mirum Pharmaceuticals, Inc C Conversion2019-07-222019-07-243,736,243— $03,736,243SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2019-07-022019-07-03350,947— $0350,947SEC↗
EPZM Epizyme, Inc. A Award2019-06-302019-07-021,868$12.55 $23.4K15,847SEC↗
EPZM Epizyme, Inc. S Sale2019-06-272019-06-2852,473$12.43 $652.2K0SEC↗
EPZM Epizyme, Inc. S Sale2019-06-262019-06-2652,472$12.85 $674.3K52,473SEC↗
EPZM Epizyme, Inc. S Sale2019-06-252019-06-2652,472$13.31 $698.4K104,945SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-09-11165,919— $08,502SEC↗
GNCA GENOCEA BIOSCIENCES, INC. P Buy2019-06-242019-06-252,857,142$3.50 $10.00M7,225,676SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-06-2638,646— $039,297SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-06-26157,417— $0157,417SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-06-26767,500— $00SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-06-26767,500— $0767,500SEC↗
EPZM Epizyme, Inc. J Other2019-06-242019-06-262,500,000— $03,971,018SEC↗
ARDX ARDELYX, INC. A Award deriv2019-06-132019-06-1750,000— $050,000SEC↗
ARDX ARDELYX, INC. A Award2019-06-132019-06-1732,846— $087,566SEC↗
NITE Nightstar Therapeutics plc D To issuer deriv2019-06-072019-06-0736,400$13.23 $481.6K0SEC↗
NITE Nightstar Therapeutics plc D To issuer deriv2019-06-072019-06-0721,000$11.93 $250.5K0SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2019-06-072019-06-1125,000— $025,000SEC↗
NITE Nightstar Therapeutics plc D To issuer2019-06-072019-06-076,662,532$25.50 $169.89M0SEC↗
EPZM Epizyme, Inc. A Award deriv2019-05-312019-06-0717,633— $017,633SEC↗
TRVI Trevi Therapeutics, Inc. C Conversion deriv2019-05-092019-05-1317,099,315— $00SEC↗
TRVI Trevi Therapeutics, Inc. P Buy2019-05-092019-05-131,500,000$10.00 $15.00M4,438,562SEC↗
TRVI Trevi Therapeutics, Inc. C Conversion2019-05-092019-05-131,938,562— $01,938,562SEC↗
TRVI Trevi Therapeutics, Inc. P Buy2019-05-092019-05-131,000,000$10.00 $10.00M2,938,562SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-05-072019-05-093,703,704$0.13 $481.5K3,703,704SEC↗
RGLS Regulus Therapeutics Inc. P Buy deriv2019-05-072019-05-09256,700$10.80 $2.77M256,700SEC↗
RGLS Regulus Therapeutics Inc. P Buy2019-05-072019-05-091,136,704$1.08 $1.23M2,052,454SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy deriv2019-04-082019-04-084,347,827$0.01 $43.5K4,347,827SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2019-04-082019-04-084,347,827$1.14 $4.96M25,243,865SEC↗
EPZM Epizyme, Inc. A Award2019-03-312019-06-071,891$12.39 $23.4K13,979SEC↗
MRSN Mersana Therapeutics, Inc. P Buy2019-03-052019-03-063,750,000$4.00 $15.00M11,890,138SEC↗
GNCA GENOCEA BIOSCIENCES, INC. P Buy deriv2019-02-142019-02-192,487,067$0.13 $323.3K2,487,067SEC↗
GNCA GENOCEA BIOSCIENCES, INC. P Buy2019-02-142019-02-199,948,269$0.47 $4.68M34,948,269SEC↗
NITE Nightstar Therapeutics plc A Award deriv2019-01-252019-01-2921,000— $021,000SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-2212,000— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-2210,000— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-2210,000— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-2210,000— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-227,290— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-2212,000— $00SEC↗
TSRO TESARO, Inc. D To issuer deriv2019-01-222019-01-224,052— $00SEC↗
TSRO TESARO, Inc. U Tender2019-01-222019-01-22739,517$75.00 $55.46M0SEC↗
TSRO TESARO, Inc. U Tender2019-01-222019-01-2215,362$75.00 $1.15M0SEC↗
TSRO TESARO, Inc. U Tender2019-01-222019-01-221,333$75.00 $100.0K0SEC↗
TSRO TESARO, Inc. U Tender2019-01-222019-01-229,681,038$75.00 $726.08M0SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2019-01-022019-01-0425,292— $025,292SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-212018-12-21300,000$1.49 $447.0K20,896,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-202018-12-21200,000$1.63 $326.0K20,596,038SEC↗
RARX Ra Pharmaceuticals, Inc. P Buy2018-12-142018-12-14645,161$15.50 $10.00M6,135,234SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-112018-12-1261,200$1.98 $121.2K20,396,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-102018-12-1026,000$1.98 $51.5K20,334,838SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-072018-12-10117,100$1.98 $231.9K20,308,838SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-12-062018-12-1027,300$1.99 $54.3K20,191,738SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-302018-11-3071,900$1.98 $142.4K20,164,438SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-282018-11-3024,500$1.99 $48.8K20,092,538SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-202018-11-21170,000$1.98 $336.6K20,068,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-192018-11-19510,000$1.88 $958.8K19,898,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-162018-11-19350,000$1.86 $651.0K19,388,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-11-152018-11-19340,000$1.86 $632.4K19,038,038SEC↗
PHAS PhaseBio Pharmaceuticals I S Sale deriv2018-10-222018-10-241,177$5.00 $5.9K3,279,627SEC↗
PHAS PhaseBio Pharmaceuticals I C Conversion deriv2018-10-222018-10-243,279,627— $00SEC↗
PHAS PhaseBio Pharmaceuticals I X Exercise deriv2018-10-222018-10-24181,190— $00SEC↗
PHAS PhaseBio Pharmaceuticals I X Exercise deriv2018-10-222018-10-24181,190$0.12 $21.7K442,055SEC↗
PHAS PhaseBio Pharmaceuticals I S Sale deriv2018-10-222018-10-244,349$5.00 $21.7K437,706SEC↗
PHAS PhaseBio Pharmaceuticals I C Conversion deriv2018-10-222018-10-24437,706— $00SEC↗
PHAS PhaseBio Pharmaceuticals I X Exercise deriv2018-10-222018-10-2449,030$0.12 $5.9K3,280,804SEC↗
PHAS PhaseBio Pharmaceuticals I X Exercise deriv2018-10-222018-10-2449,030— $00SEC↗
PHAS PhaseBio Pharmaceuticals I C Conversion deriv2018-10-222018-10-241,124,301— $00SEC↗
PHAS PhaseBio Pharmaceuticals I P Buy2018-10-222018-10-241,800,000$5.00 $9.00M6,641,634SEC↗
PHAS PhaseBio Pharmaceuticals I C Conversion2018-10-222018-10-244,841,634— $04,841,634SEC↗
ESTC Elastic N.V. C Conversion deriv2018-10-102018-10-104,155,995— $00SEC↗
ESTC Elastic N.V. C Conversion deriv2018-10-102018-10-101,528,117— $00SEC↗
ESTC Elastic N.V. C Conversion2018-10-102018-10-104,155,995— $04,155,995SEC↗
ESTC Elastic N.V. C Conversion2018-10-102018-10-101,528,117— $01,528,117SEC↗
EPZM Epizyme, Inc. P Buy2018-10-052018-10-05416,667$9.00 $3.75M6,471,018SEC↗
MRSN Mersana Therapeutics, Inc. A Award deriv2018-09-202018-09-2110,000— $010,000SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-09-072018-09-1012,000,000$1.67 $20.04M12,000,000SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-09-072018-09-103,000,000$1.67 $5.01M82,978,668SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-08-212018-08-22663,716$2.26 $1.50M18,698,038SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-07-192018-07-2050,600$2.00 $101.2K18,034,322SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-07-182018-07-20200,000$1.95 $390.0K17,983,722SEC↗
EPZM Epizyme, Inc. A Award2018-07-022018-07-026,088$13.55 $82.5K12,088SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-06-282018-06-28187,130$2.10 $393.0K17,783,722SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-06-272018-06-285,295$2.15 $11.4K17,596,592SEC↗
ADAP Adaptimmune Therapeutics P A Award deriv2018-06-222018-06-26187,330— $0187,330SEC↗
ARDX ARDELYX, INC. A Award deriv2018-06-132018-06-1515,000— $015,000SEC↗
ARDX ARDELYX, INC. A Award2018-06-132018-06-1520,843— $054,720SEC↗
TSRO TESARO, Inc. A Award deriv2018-06-012018-06-057,209— $07,209SEC↗
TSRO TESARO, Inc. A Award deriv2018-06-012018-06-054,052— $04,052SEC↗
TSRO TESARO, Inc. A Award2018-06-012018-06-052,537— $015,362SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-05-302018-05-30275$2.15 $59117,591,297SEC↗
ARDX ARDELYX, INC. A Award2018-05-252018-05-30416,666$4.00 $1.67M3,082,186SEC↗
ARDX ARDELYX, INC. A Award2018-05-252018-05-30416,667$4.00 $1.67M3,082,186SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-05-212018-05-2132,200$2.14 $68.9K17,591,022SEC↗
EPZM Epizyme, Inc. A Award deriv2018-05-182018-05-3112,500— $012,500SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-05-182018-05-2120,100$2.14 $43.0K17,558,822SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-05-172018-05-21184,179$2.13 $392.3K17,538,722SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-05-082018-05-1070,873$2.13 $151.0K17,354,543SEC↗
MULE MULESOFT, INC C Conversion deriv2018-05-012018-05-0912,679,970— $00SEC↗
MULE MULESOFT, INC C Conversion deriv2018-05-012018-05-09858,978— $00SEC↗
MULE MULESOFT, INC C Conversion deriv2018-05-012018-05-092,576,939— $00SEC↗
MULE MULESOFT, INC C Conversion2018-05-012018-05-09858,978— $0858,978SEC↗
MULE MULESOFT, INC C Conversion2018-05-012018-05-0912,679,970— $012,679,970SEC↗
MULE MULESOFT, INC U Tender2018-05-012018-05-0912,679,970— $00SEC↗
MULE MULESOFT, INC C Conversion2018-05-012018-05-092,576,939— $02,576,939SEC↗
MULE MULESOFT, INC U Tender2018-05-012018-05-092,576,939— $00SEC↗
MULE MULESOFT, INC U Tender2018-05-012018-05-09858,978— $00SEC↗
SURF Surface Oncology, Inc. C Conversion deriv2018-04-232018-04-236,995,000— $00SEC↗
SURF Surface Oncology, Inc. C Conversion2018-04-232018-04-233,179,544— $03,179,544SEC↗
SURF Surface Oncology, Inc. P Buy2018-04-232018-04-23133,333$15.00 $2.00M3,312,877SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-04-102018-04-10203,200$2.46 $499.9K17,283,670SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-04-092018-04-1032,100$2.43 $78.0K17,080,470SEC↗
AVEO AVEO PHARMACEUTICALS INC P Buy2018-04-062018-04-10685,676$2.24 $1.54M17,048,370SEC↗
TCON Tracon Pharmaceuticals, In P Buy deriv2018-03-272018-03-27707,964$0.13 $92.0K707,964SEC↗
TCON Tracon Pharmaceuticals, In P Buy2018-03-272018-03-27707,964$2.70 $1.91M3,466,003SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-03-272018-03-286,000,000$1.92 $11.52M79,978,672SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-03-262018-03-28571,164$1.90 $1.09M73,978,672SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-03-232018-03-23294,090$1.95 $573.5K73,407,508SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-03-222018-03-23869,574$1.90 $1.65M73,113,418SEC↗
ADAP Adaptimmune Therapeutics P P Buy2018-03-212018-03-23104,844$1.81 $189.8K72,243,844SEC↗
CASC Cascadian Therapeutics, In U Tender2018-03-092018-03-1310,882,574— $00SEC↗
TSRO TESARO, Inc. P Buy2018-03-062018-03-0612,634$59.82 $755.8K9,681,129SEC↗
TSRO TESARO, Inc. P Buy2018-03-062018-03-063,159$59.82 $189.0K739,516SEC↗
TSRO TESARO, Inc. P Buy2018-03-052018-03-064,311$59.76 $257.6K736,357SEC↗